Literature DB >> 23598495

The imperative for stronger vaccine supply and logistics systems.

Michel Zaffran1, Jos Vandelaer, Debra Kristensen, Bjørn Melgaard, Prashant Yadav, K O Antwi-Agyei, Heidi Lasher.   

Abstract

With the introduction of new vaccines, developing countries are facing serious challenges in their vaccine supply and logistics systems. Storage capacity bottlenecks occur at national, regional, and district levels and system inefficiencies threaten vaccine access, availability, and quality. As countries adopt newer and more expensive vaccines and attempt to reach people at different ages and in new settings, their logistics systems must be strengthened and optimized. As a first step, national governments, donors, and international agencies have crafted a global vision for 2020 vaccine supply and logistics systems with detailed plans of action to achieve five priority objectives. Vaccine products and packaging are designed to meet the needs of developing countries. Immunization supply systems support efficient and effective vaccine delivery. The environmental impact of energy, materials, and processes used in immunization systems is minimized. Immunization information systems enable better and more timely decision-making. Competent and motivated personnel are empowered to handle immunization supply chain issues. Over the next decade, vaccine supply and logistics systems in nearly all developing countries will require significant investments of time and resources from global and national partners, donors, and governments. These investments are critical if we are to reach more people with current and newer vaccines.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23598495     DOI: 10.1016/j.vaccine.2012.11.036

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  38 in total

1.  Evaluation of the thermal stability and the protective efficacy of spray-dried HPV vaccine, Gardasil® 9.

Authors:  Nitesh K Kunda; Julianne Peabody; Lukai Zhai; Dominique N Price; Bryce Chackerian; Ebenezer Tumban; Pavan Muttil
Journal:  Hum Vaccin Immunother       Date:  2019-04-19       Impact factor: 3.452

2.  Enhancing the work of the Department of Health and Human Services national vaccine program in global immunization: recommendations of the National Vaccine Advisory Committee: approved by the National Vaccine Advisory Committee on September 12, 2013.

Authors: 
Journal:  Public Health Rep       Date:  2014       Impact factor: 2.792

Review 3.  Challenges for nationwide vaccine delivery in African countries.

Authors:  Mario Songane
Journal:  Int J Health Econ Manag       Date:  2017-10-19

4.  The PD-1 Regulatory Axis Inhibits T Cell-Independent B Cell Memory Generation and Reactivation.

Authors:  M Ariel Spurrier; Jamie E Jennings-Gee; Christina A Daly; Karen M Haas
Journal:  J Immunol       Date:  2021-09-17       Impact factor: 5.426

5.  Vaccine wastage in Nigeria: An assessment of wastage rates and related vaccinator knowledge, attitudes and practices.

Authors:  Aaron S Wallace; Fred Willis; Eric Nwaze; Boubacar Dieng; Naawa Sipilanyambe; Danni Daniels; Emmanuel Abanida; Alex Gasasira; Mustapha Mahmud; Tove K Ryman
Journal:  Vaccine       Date:  2017-10-21       Impact factor: 3.641

6.  Economic benefits of keeping vaccines at ambient temperature during mass vaccination: the case of meningitis A vaccine in Chad.

Authors:  Patrick Lydon; Simona Zipursky; Carole Tevi-Benissan; Mamoudou Harouna Djingarey; Placide Gbedonou; Brahim Oumar Youssouf; Michel Zaffran
Journal:  Bull World Health Organ       Date:  2013-11-04       Impact factor: 9.408

7.  Health system cost of delivering routine vaccination in low- and lower-middle income countries: what is needed over the next decade?

Authors:  Patrick Lydon; Gian Gandhi; Jos Vandelaer; Jean-Marie Okwo-Bele
Journal:  Bull World Health Organ       Date:  2014-02-07       Impact factor: 9.408

8.  Distributing Publicly-Funded Influenza Vaccine-Community Pharmacies' Perspectives on Acquiring Vaccines from Public Health and from Private Distributors in Ontario, Canada.

Authors:  Joseph Fonseca; Richard Violette; Sherilyn K D Houle; Nancy M Waite
Journal:  Pharmacy (Basel)       Date:  2021-04-24

9.  Formulation of Nanovaccines toward an Extended Immunity against Nicotine.

Authors:  Yun Hu; Zongmin Zhao; Marion Ehrich; Chenming Zhang
Journal:  ACS Appl Mater Interfaces       Date:  2021-06-09       Impact factor: 10.383

10.  Optimized supply chain model reduces health system costs in DRC.

Authors:  Dorothy Thomas; Eomba Motomoke; Jessica Crawford; Olivier Defawe; Archimede Makaya; Jean Willy Ngwato; Joel Bompongo; Jose Monzembela; Gabriella Ailstock; Emily Bancroft; Bvudzai Magadzire; Dominique Baabo; Noel Watson
Journal:  Vaccine       Date:  2021-06-12       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.